Stage IIB Prostate Cancer Completed Phase 2 Trials for Broxuridine (DB12028)

IndicationStatusPhase
DBCOND0028879 (Stage IIB Prostate Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003832Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate CancerTreatment